Status:
UNKNOWN
Measurement of Noradrenaline Concentrations Using Different Dilution Methods
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Arterial Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Norepinephrine is the vasopressor of choice for the treatment of peri-anesthetic arterial hypotension. The use of this drug at significantly lower concentrations (dilution factor between 40 and 200) t...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult person,
- Employee of Strasbourg University Hospitals,
- Likely to have to prepare anesthesia drugs in the operating room (intern, hospital student, IADE, IADE student)
- Exclusion criteria:
- \- Subject's refusal to participate in the study
Exclusion
Key Trial Info
Start Date :
February 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04772599
Start Date
February 21 2021
End Date
July 1 2021
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Strasbourg University Hospitals - Anesthesia-intensive care unit
Strasbourg, France, 67091